Allen Steere

Q: What Schools Are Affiliated With Allen Steere

Allen Steere is affiliated with the following schools: Yale University, Tufts University, Massachusetts General Hospital, Harvard University

Allen Steere's AcademicInfluence.com Rankings

Allen Steere

Philosophy

#3747

World Rank

#6002

Historical Rank

#1158

USA Rank

Logic

#1374

World Rank

#2113

Historical Rank

#413

USA Rank

philosophy Degrees

Download Badge

Philosophy

Allen Steere's Degrees

Doctorate Medicine Harvard University

Why Is Allen Steere Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Allen Caruthers Steere is an American rheumatologist. He is a professor of rheumatology at Harvard University and previously at Tufts University and Yale University. Steere and his mentor, Stephen Malawista of Yale University, are credited with discovering and naming Lyme disease, and he has published almost 300 scholarly articles on Lyme disease during his more than 40 years of studies of this infection. At a ceremony in Hartford, Connecticut in 1998, Governor John G. Rowland declared September 24 to be "Allen C. Steere Day."

(See a Problem?)

Allen Steere's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. (2006) (1859)
The spirochetal etiology of Lyme disease. (1983) (1505)
Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. (1977) (1181)
Medical progress. Lyme disease (1989) (994)
The emergence of Lyme disease. (2004) (795)
The clinical evolution of Lyme arthritis. (1987) (716)
Western blotting in the serodiagnosis of Lyme disease. (1993) (676)
Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. (1977) (613)
The early clinical manifestations of Lyme disease. (1983) (606)
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. (1994) (573)
The triad of neurologic manifestations of Lyme disease (1985) (555)
Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. (1998) (514)
Lyme carditis: cardiac abnormalities of Lyme disease. (1980) (513)
Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. (1998) (499)
A critical appraisal of "chronic Lyme disease". (2007) (474)
Lyme disease. (1989) (441)
Neurologic Abnormalities of Lyme Disease (1979) (422)
Antibody response in Lyme disease: evaluation of diagnostic tests. (1984) (380)
Treatment of the early manifestations of Lyme disease. (1983) (374)
Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. (1986) (342)
Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. (2000) (339)
A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. (1986) (318)
Erratum: The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America (Clinical Infectious Diseases (2006) 43, (1089-1134)) (2007) (308)
ASSOCIATION OF CHRONIC LYME ARTHRITIS WITH HLA‐DR4 and HLA‐DR2 ALLELES (1990) (299)
Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. (1978) (285)
Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi (1993) (282)
Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. (2001) (277)
The T-cell proliferative assay in the diagnosis of Lyme disease. (1991) (276)
Sensitive and Specific Serodiagnosis of Lyme Disease by Enzyme-Linked Immunosorbent Assay with a Peptide Based on an Immunodominant Conserved Region of Borrelia burgdorferi VlsE (1999) (275)
Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini. (1979) (274)
Serodiagnosis of Lyme Disease by Kinetic Enzyme-Linked Immunosorbent Assay Using Recombinant VlsE1 or Peptide Antigens of Borrelia burgdorferi Compared with 2-Tiered Testing Using Whole-Cell Lysates (2003) (271)
Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. (1988) (267)
Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. (1979) (258)
Treatment of Lyme arthritis. (1994) (257)
Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. (1983) (255)
The Long-Term Clinical Outcomes of Lyme Disease: A Population-Based Retrospective Cohort Study (1994) (253)
Prospective study of serologic tests for lyme disease. (2008) (249)
Laboratory Evaluation in the Diagnosis of Lyme Disease (1997) (249)
Chronic neurologic manifestations of Lyme disease. (1990) (246)
Clinical Characteristics and Treatment Outcome of Early Lyme Disease in Patients with Microbiologically Confirmed Erythema Migrans (2002) (242)
Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. (1979) (240)
Evidence of the Immune Relevance of Prevotella copri, a Gut Microbe, in Patients With Rheumatoid Arthritis (2017) (237)
Elucidation of Lyme arthritis (2004) (227)
The overdiagnosis of Lyme disease. (1993) (217)
Successful parenteral penicillin therapy of established Lyme arthritis. (1985) (212)
Antibiotic therapy in Lyme disease. (1980) (212)
Lyme arthritis. Spirochetes found in synovial microangiopathic lesions. (1985) (212)
Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue. (1988) (211)
Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. (1986) (210)
Lyme borreliosis. (2016) (210)
High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. (1988) (210)
Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. (1985) (209)
Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. (2006) (209)
Lyme disease associated with fibromyalgia. (1992) (196)
Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. (1985) (192)
Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis (1993) (190)
Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide (2006) (189)
Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. (1983) (185)
Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. (1990) (182)
Clinical Pathologic Correlations of Lyme Disease by Stage (1988) (178)
T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. (1998) (177)
Diagnosing early Lyme disease. (1985) (167)
The presenting manifestations of Lyme disease and the outcomes of treatment. (2003) (164)
Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. (2000) (163)
Evaluation of study patients with Lyme disease, 10-20-year follow-up. (2001) (153)
A Genome-Wide Proteome Array Reveals a Limited Set of Immunogens in Natural Infections of Humans and White-Footed Mice with Borrelia burgdorferi (2008) (152)
Central nervous system manifestations of Lyme disease. (1989) (150)
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. (1996) (150)
Human Antibody Responses to VlsE Antigenic Variation Protein of Borrelia burgdorferi (1999) (148)
The long-term course of Lyme arthritis in children. (1991) (147)
The Immunoglobulin (IgG) Antibody Response to OspA and OspB Correlates with Severe and Prolonged Lyme Arthritis and the IgG Response to P35 Correlates with Mild and Brief Arthritis (1999) (145)
Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay. (2011) (140)
Facial paralysis in lyme disease (1985) (139)
Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. (1988) (139)
Two rheumatoid arthritis–specific autoantigens correlate microbial immunity with autoimmune responses in joints (2017) (135)
Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection (1994) (134)
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. (2013) (132)
The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis (1994) (130)
Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis. (2011) (130)
The clinical spectrum and treatment of Lyme disease. (1984) (129)
A prospective study of tick bites in an endemic area for Lyme disease. (1989) (126)
Clinical and electrophysiologic findings in chronic neuropathy of Lyme disease (1992) (123)
Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. (1999) (122)
Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis. (2012) (121)
Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis. (2001) (120)
Arthritis caused by Borrelia burgdorferi in dogs. (1985) (119)
Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. (1979) (118)
Serodiagnosis of early Lyme disease: analysis of IgM and IgG antibody responses by using an antibody-capture enzyme immunoassay. (1988) (118)
Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis. (1994) (117)
Molecular Mimicry in Lyme Arthritis Demonstrated at the Single Cell Level: LFA-1αL Is a Partial Agonist for Outer Surface Protein A-Reactive T Cells1 (2001) (115)
Treatment of early Lyme disease. (1992) (114)
Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. (2008) (114)
Lyme disease: a growing threat to urban populations. (1994) (112)
High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory lyme arthritis. (2007) (112)
Diagnosis and treatment of Lyme arthritis. (2015) (111)
Lyme borreliosis (2016) (109)
Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi. (1985) (105)
Antiscience and ethical concerns associated with advocacy of Lyme disease. (2011) (105)
Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity. (1979) (105)
Diagnosis and treatment of Lyme arthritis. (1997) (104)
Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. (1999) (100)
Memory impairment and depression in patients with Lyme encephalopathy (1992) (99)
Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. (1998) (98)
Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood. (1986) (98)
Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease. (2011) (96)
Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease (1995) (95)
Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. (1999) (95)
Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. (2000) (93)
Guidelines for Laboratory Evaluation in the Diagnosis of Lyme Disease (1997) (91)
2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test. (2010) (91)
Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. (2003) (91)
Prospective study of coinfection in patients with erythema migrans. (2003) (89)
Lyme arthritis: radiologic findings. (1985) (89)
Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans. (2014) (87)
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. (2020) (87)
Optic neuropathy in children with Lyme disease. (2001) (86)
Asymptomatic infection with Borrelia burgdorferi. (2003) (86)
Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii. (2009) (85)
Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy. (1991) (84)
Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis (2019) (82)
Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis. (2011) (82)
Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease (2017) (81)
Borrelia burgdorferi Genetic Markers and Disseminated Disease in Patients with Early Lyme Disease (2006) (80)
Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut (2006) (80)
Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays. (1979) (79)
Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. (2003) (79)
Lyme myositis: muscle invasion by Borrelia burgdorferi. (1988) (77)
DNA characterization of the spirochete that causes Lyme disease (1984) (77)
Recovery of Lyme disease spirochetes from patients. (1984) (77)
Advances in Serodiagnostic Testing for Lyme Disease Are at Hand (2018) (77)
Host metalloproteinases in Lyme arthritis. (2001) (75)
Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe. (2013) (73)
Erythema chronicum migrans and Lyme arthritis: cryoimmunoglobulins and clinical activity of skin and joints. (1977) (72)
A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease. (2013) (72)
Differences in Genotype, Clinical Features, and Inflammatory Potential of Borrelia burgdorferi sensu stricto Strains from Europe and the United States (2016) (71)
Antigen‐specific proliferation of CSF lymphocytes in Lyme disease (1985) (70)
Intralaboratory reliability of serologic and urine testing for Lyme disease. (2001) (70)
Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist. (1992) (70)
Possible nosocomial transmission of group B streptococci in a newborn nursery. (1975) (69)
Anticardiolipin antibodies in Lyme disease. (1988) (69)
Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. (2003) (68)
Chemokine Signatures in the Skin Disorders of Lyme Borreliosis in Europe: Predominance of CXCL9 and CXCL10 in Erythema Migrans and Acrodermatitis and CXCL13 in Lymphocytoma (2007) (68)
Expression of Adhesion Molecules in Synovia of Patients with Treatment-Resistant Lyme Arthritis (2001) (67)
Musculoskeletal manifestations of Lyme disease. (1995) (67)
Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis (2013) (67)
Test-Treatment Strategies for Patients Suspected of Having Lyme Disease: A Cost-Effectiveness Analysis (1998) (66)
An Animal Model for Lyme Arthritis a (1988) (65)
Cellular and Humoral Immune Responses toBorrelia burgdorferi Antigens in Patients with Culture-Positive Early Lyme Disease (2001) (65)
Urinary fluoride levels associated with use of fluoridated waters. (1956) (65)
Dysregulation of CD4+CD25(high) T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis. (2013) (63)
Empirical Parenteral Antibiotic Treatment of Patients with Fibromyalgia and Fatigue and a Positive Serologic Result for Lyme Disease: A Cost-Effectiveness Analysis (1993) (63)
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease (2020) (62)
The antibody response in Lyme disease. (1984) (62)
Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis. (2010) (62)
A cluster of Mycobacterium gordonae isolates from bronchoscopy specimens. (1979) (62)
Induction of Host Matrix Metalloproteinases by Borrelia burgdorferi Differs in Human and Murine Lyme Arthritis (2005) (62)
Reversible cerebral hypoperfusion in Lyme encephalopathy (1997) (61)
Neurocognitive abnormalities in children after classic manifestations of Lyme disease. (1998) (60)
Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis (1996) (60)
Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis. (2007) (60)
Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis. (2009) (60)
Multiplex Immunoassay for Lyme Disease Using VlsE1-IgG and pepC10-IgM Antibodies: Improving Test Performance through Bioinformatics (2011) (59)
Experimental Lyme disease in rabbits: spirochetes found in erythema migrans and blood (1984) (58)
Higher mRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme borreliosis. (2008) (58)
Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells. (1991) (56)
Elevated levels of collagenase and prostaglandin e2 from synovium associated with chronic lyme arthritis (1980) (54)
Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosides (1993) (54)
Direct Diagnostic Tests for Lyme Disease (2018) (53)
Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. (1997) (52)
Neurological findings of Lyme disease. (1984) (51)
Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells. (1994) (51)
T-Helper 17 Cell Cytokine Responses in Lyme Disease Correlate With Borrelia burgdorferi Antibodies During Early Infection and With Autoantibodies Late in the Illness in Patients With Antibiotic-Refractory Lyme Arthritis (2017) (49)
Borrelia burgdorferi infection regulates CD1 expression in human cells and tissues via IL1‐β (2011) (48)
Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment. (2001) (48)
Fatal adult respiratory distress syndrome in a patient with Lyme disease. (1988) (47)
Urinary excretion of fluoride following defluoridation of a water supply. (1956) (46)
In Situ Diversification of the Antibody Repertoire in Chronic Lyme Arthritis Synovium1 (2005) (46)
Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthritis Following Lyme Disease (2017) (45)
Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. (1998) (45)
Ixodes ricinus spirochete and European erythema chronicum migrans disease. (1984) (44)
Seronegative Lyme disease. (1993) (44)
Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation. (1996) (44)
Peptides Presented by HLA-DR Molecules in Synovia of Patients with Rheumatoid Arthritis or Antibiotic-Refractory Lyme Arthritis* (2010) (44)
T cell responses to polypeptide fractions of Borrelia burgdorferi in patients with Lyme arthritis. (1991) (43)
Cellular immune findings in Lyme disease. Correlation with serum IgM and disease activity. (1984) (43)
In vivo and in vitro evidence of B cell hyperactivity during Lyme disease. (1988) (43)
Lyme borreliosis in the Soviet Union: a cooperative US-USSR report. (1988) (41)
Pseudomonas species bacteremia caused by contaminated normal human serum albumin. (1977) (41)
Newly recognized Leptospira species ("Leptospira inadai" serovar lyme) isolated from human skin (1986) (41)
Annexin A2 is a target of autoimmune T and B cell responses associated with synovial fibroblast proliferation in patients with antibiotic-refractory Lyme arthritis. (2015) (41)
Nonprotein antigens of Borrelia burgdorferi. (1993) (40)
Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis. (2000) (40)
Antibodies to Endothelial Cell Growth Factor and Obliterative Microvascular Lesions in the Synovium of Patients With Antibiotic‐Refractory Lyme Arthritis (2014) (40)
Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. (2004) (39)
Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis. (2016) (38)
CNS manifestations of third stage Lyme disease. (1987) (38)
Natural killer cells and natural killer T cells in Lyme arthritis (2013) (38)
Antigens of Borrella burgdorferi Recognized during Lyme Disease (37)
Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis. (2017) (37)
Neuropsychological deficits in Lyme disease patients with and without other evidence of central nervous system pathology. (1999) (37)
A Highly Expressed Human Protein, Apolipoprotein B-100, Serves as an Autoantigen in a Subgroup of Patients With Lyme Disease. (2015) (37)
Possible nosocomial transmission of group Y Neisseria meningitidis among oncology patients. (1979) (36)
Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease (2015) (36)
Soluble CD14 levels in the serum, synovial fluid, and cerebrospinal fluid of patients with various stages of Lyme disease. (2000) (36)
Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis. (2008) (36)
Immune responses to borrelial VlsE IR6 peptide variants. (2007) (35)
Ultrastructural differences among spirochetes isolated from patients with Lyme disease and related disorders, and from Ixodes ricinus. (1986) (35)
Inflammatory Cytokine Production Predominates in Early Lyme Disease in Patients with Erythema Migrans (2003) (35)
Role of aggrecanase 1 in Lyme arthritis. (2006) (34)
Lyme disease. (2001) (34)
Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritis. (2008) (34)
The pathogenesis of arthritis in Lyme disease: humoral immune responses and the role of intra-articular immune complexes. (1984) (33)
Surveillance of Lyme disease in the United States, 1982. (1985) (33)
Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis. (1993) (33)
The spectrum of organ and systems pathology in human Lyme disease. (1986) (33)
Bilateral keratitis in Lyme disease. (1989) (33)
IgM rheumatoid factor in Lyme disease: correlation with disease activity, total serum IgM, and IgM antibody to Borrelia burgdorferi. (1987) (32)
Lack of antibodies to Borrelia burgdorferi in patients with amyotrophic lateral sclerosis. (1989) (32)
GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA Practice Guidelines for the Treatment of Lyme Disease (2008) (31)
Hepatitis B infection in hospital personnel during an eight-year period; policies for screening and pregnancy in high risk areas. (1981) (31)
Recognition of Multiple Antibody Epitopes throughout Borrelia burgdorferi p66, a Candidate Adhesin, in Patients with Early or Late Manifestations of Lyme Disease (2001) (29)
Decline in the Frequencies of Borrelia burgdorferi OspA161–175-Specific T Cells after Antibiotic Therapy in HLA-DRB1*0401-Positive Patients with Antibiotic-Responsive or Antibiotic-Refractory Lyme Arthritis1 (2007) (29)
The VlsE (IR6) Peptide ELISA in the Serodiagnosis of Lyme Facial Paralysis (2004) (29)
MicroRNA Expression Shows Inflammatory Dysregulation and Tumor‐Like Proliferative Responses in Joints of Patients With Postinfectious Lyme Arthritis (2017) (28)
Elevated levels of collagenase and prostaglandin E2 from synovium associated with erosion of cartilage and bone in a patient with chronic Lyme arthritis. (1980) (28)
Maternal-fetal transmission of the lyme disease spirochete, borrelia burgdorferi (1986) (25)
Characterization of the early local immune response to Ixodes ricinus tick bites in human skin (2017) (25)
Strong IgG antibody responses to Borrelia burgdorferi glycolipids in patients with Lyme arthritis, a late manifestation of the infection. (2009) (24)
Cellular immune findings in Lyme disease. (1984) (23)
Cerebellar ataxia as the presenting manifestation of Lyme disease. (2002) (23)
Borrelia burgdorferi (Lyme Disease, Lyme Borreliosis) (2010) (23)
Lyme disease: infectious in origin, rheumatic in expression. (1986) (22)
Robust interferon signature and suppressed tissue repair gene expression in synovial tissue from patients with postinfectious, Borrelia burgdorferi‐induced Lyme arthritis (2018) (22)
Clinical manifestations of Lyme disease. (1986) (22)
Pathogenesis of Lyme Arthritis Implications for Rheumatic Disease a (1988) (21)
Clinical definitions and differential diagnosis of Lyme arthritis. (1991) (21)
Neutrophil chemotactic factors in synovial fluids of patients with Lyme disease. (1991) (21)
Interferon‐gamma production in Lyme arthritis synovial tissue promotes differentiation of fibroblast‐like synoviocytes into immune effector cells (2019) (21)
Current understanding of Lyme disease. (1993) (20)
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. (2021) (20)
Lyme arthritis: linking infection, inflammation and autoimmunity (2021) (20)
Borrelia burgdorferi stimulation of chemokine secretion by cells of monocyte lineage in patients with Lyme arthritis (2010) (20)
Effect of calcium treatment on solubility and calcium uptake of synthetic hydroxyapatite and rat molar enamel. (1958) (19)
Lyme arthritis: a new clinical entity. (1978) (19)
Infection in rabbits with the Lyme disease spirochete. (1984) (19)
Treatment of Lyme disease. (1987) (18)
A 58-year-old man with a diagnosis of chronic lyme disease. (2002) (18)
Pyrogen Reactions Associated with the Infusion of Normal Serum Albumin (Human) (1978) (17)
Molecular analysis of the role of the HLA class II genes DRB1, DQA1, DQB1, and DPB1 in susceptibility to Lyme arthritis. (1991) (17)
Case records of the Massachusetts General Hospital. Case 11-2007. A 59-year-old man with neck pain, weakness in the arms, and cranial-nerve palsies. (2007) (16)
Cross-reactivity of Borrelia burgdorferi and myelin basic protein-specific T cells is not observed in borrelial encephalomyelitis. (1999) (16)
Laboratory Diagnosis of Lyme Borreliosis (2021) (16)
Human Lyme Arthritis and the Immunoglobulin G Antibody Response to the 37-Kilodalton Arthritis-Related Protein of Borrelia burgdorferi (2005) (15)
Reply to letter by Volkman commenting on the possible onset of seronegative disease in Lyme arthritis. (2009) (14)
Lyme disease: a unique human model for an infectious etiology of rheumatic disease. (1984) (14)
Symmetric polyarthritis associated with heterophile-negative infectious mononucleosis. (1983) (14)
Reinfection versus relapse in Lyme disease. (2012) (14)
Duration of Antibiotic Therapy for Lyme Disease (2003) (13)
Spirochetes in atrophic skin lesions accompanied by minimal host response in a child with Lyme disease. (1991) (13)
243 – Lyme Disease (Lyme Borreliosis) Due to Borrelia burgdorferi (2015) (13)
Tick-specific borrelial antigens appear to be upregulated in American but not European patients with Lyme arthritis, a late manifestation of Lyme borreliosis. (2013) (12)
Deposition and retention of fluoride and radiocalcium in the growing rat. (1959) (12)
Posttreatment Lyme disease syndromes: distinct pathogenesis caused by maladaptive host responses. (2020) (12)
Correlation of Lyme Disease–Associated IgG4 Autoantibodies With Synovial Pathology in Antibiotic‐Refractory Lyme Arthritis (2018) (12)
Increased IgA rheumatoid factor and VH1 associated cross reactive idiotype expression in patients with Lyme arthritis and neuroborreliosis (1999) (12)
Molecular mimicry and Lyme arthritis. (2001) (12)
Identification of Novel, Immunogenic HLA–DR‐Presented Prevotella copri Peptides in Patients With Rheumatoid Arthritis (2021) (11)
Case records of the Massachusetts General Hospital. Case 14-2005. A 38-year-old man with fever and blurred vision. (2005) (11)
Lyme Arthritis: Oligoclonal Anti‐Borrelia burgdorferi IgG Antibodies Occur in Joint Fluid and Serum (1991) (11)
CD1b presents self and Borrelia burgdorferi diacylglycerols to human T cells (2019) (10)
DNA characterization of Lyme disease spirochetes. (1984) (9)
Hyperparathyroidism in pregnancy with sonographic documentation of a parathyroid adenoma. A case report. (1985) (8)
Successful treatment of a patient with chronic Lyme arthritis with extracorporeal photochemotherapy. (1994) (8)
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease (2020) (8)
Lyme disease. (2019) (8)
Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion. (2007) (7)
Treatment of Lyme Arthritis (2019) (7)
Identification of a T Cell Subset Capable of both IFN-γ and IL-10 Secretion in Patients with Chronic Borrelia burgdorferi Infection (1998) (7)
Historical perspective of Lyme disease. (1986) (7)
Erythema chronicum migrans and Lyme arthritis: related problems recently recognized in Connecticut. (1978) (6)
Guidelines for the Clinical Diagnosis of Lyme Disease (1998) (6)
Expression of public idiotypes in patients with Lyme arthritis. (1993) (5)
Editorial commentary: what constitutes appropriate treatment of post-Lyme disease symptoms and other pain and fatigue syndromes? (2015) (5)
Clinical and serologic features of Lyme borreliosis in Russia. (1995) (5)
[Spirochete etiology of erythema chronicum migrans disease]. (1984) (5)
Borrelia burgdorferi Chronic and IL-10 Secretion in Patients with γ IFN-Identification of a T Cell Subset Capable of both (1998) (5)
[Lyme arthritis: the joint lesions in Lyme borreliosis in the USA]. (1995) (4)
Correction: Lyme borreliosis (2017) (4)
[A review of Lyme disease]. (1989) (4)
Periodontal inflammation and distinct inflammatory profiles in saliva and GCF compared with serum and joints in rheumatoid arthritis patients. (2021) (4)
Identification of a T Cell Subset Capable of both IFN-g and IL-10 Secretion in Patients with Chronic Borrelia burgdorferi Infection (1998) (4)
Aliskiren in Type 2 Diabetes and Cardiorenal End Points (2013) (4)
OP0116 Identification of N-Acetylglucosamine-6-Sulfatase and Filamin a as Novel Targets of Autoimmune T and B Cell Responses in Rheumatoid Arthritis (2015) (3)
Case 11-2007 : A 59-Year-Old Man with Neck Pain , Weakness in the Arms , and Cranial-Nerve Palsies (2007) (3)
Lyme disease--1993. (1993) (3)
Evidence for Pseudomonas antigen in immune complexes in Pseudomonas osteomyelitis. (1982) (3)
Correlation with Serum IgM and Disease Activity (1984) (3)
Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology (2020) (3)
Reply to Pollock, Donta, Wilson, and Arne (2007) (3)
Erratum to “Searching for Borrelial T cell Epitopes associated with antibiotic-refractory lyme arthritis” [Mol. Immunol. 45 (2008) 2323–2332] (2008) (3)
Treatment of Lyme disease. (1987) (3)
Current Concepts A Critical Appraisal of “ Chronic Lyme Disease ” (2007) (2)
34 – Lyme Disease Vaccines (2018) (2)
Role of Adrenomedullin in Lyme Disease (2010) (2)
Association of Antibodies to Prevotella copri in Anti–Cyclic Citrullinated Peptide‐Positive Individuals At Risk of Developing Rheumatoid Arthritis and in Patients With Early or Established Rheumatoid Arthritis (2022) (2)
Pseudomonas Species Bacteremia Caused by Contaminated (1977) (2)
Anti‐Fab Antibodies in Lyme Disease (1988) (2)
7 Lyme disease (1998) (2)
Chronic Lyme Arthritis (2020) (2)
[Lyme disease--a tick-transmitted spirochete infection]. (1987) (2)
Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays (2022) (2)
Author response for "CD1b presents self and Borrelia burgdorferi diacylglycerols to human T cells" (2019) (1)
[Epidemiological study of Lyme disease in Brazil]. (1992) (1)
Effect of calcium treatment on solubility and calcium uptake of synthetic hydroxyapatite and rat molar enamel: : progress report (1957) (1)
Management of Pediatric Lyme Disease: Updates From 2020 Lyme Guidelines. (2022) (1)
Musculoskeletal manifestations of lyme disease. Discussion (1995) (1)
Seronegative Lyme disease. (1993) (1)
A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF REPEATED IV ANTIBIOTIC THERAPY FOR LYME ENCEPHALOPATHY PROLONGED LYME DISEASE TREATMENT: ENOUGH IS ENOUGH (2009) (1)
The Overdiagnosis of Lyme Disease-Reply (1993) (1)
Reply to Stricker and Johnson (2008) (1)
Pathogenesis, Diagnosis and Treatment of Lyme Arthritis (1994) (1)
Synovium Repertoire in Chronic Lyme Arthritis In Situ Diversification of the Antibody (2005) (0)
32 - Infection and Autoimmunity in Patients with Antibiotic Treatment-Resistant Lyme Arthritis (2004) (0)
Reply to Naktin. (2017) (0)
Possible nosocomial transmission streptococci in a newborn nursery of group B (1975) (0)
EFFECTIVENESS OF EARLY LYME DISEASE TREATMENT. AUTHOR'S REPLY (1993) (0)
OPENING PANDORA ' S BOX OF TICK-BORNE DISEASES (2017) (0)
The host population perspective in pathogen defense: Clues from borrelia burgdorferi and HLA (2005) (0)
Improving the Diagnosis and Treatment of Borrelia burgdorferi Infections: An Ongoing Challenge (2016) (0)
52 – Lyme disease vaccines (2013) (0)
Early disseminated lyme disease : lyme meningitis. Discussion (1995) (0)
THE OVERDIAGNOSIS OF LYME DISEASE. AUTHOR'S REPLY (1993) (0)
Reinfection versus relapse in Lyme disease. (2013) (0)
Reply to Parvu and Parvu. (2014) (0)
Natural killer cells and natural killer T cells in (2013) (0)
Identiﬁcation of a T Cell Subset Capable of both IFN- g and IL-10 Secretion in Patients with Chronic Borrelia burgdorferi Infection 1 (1998) (0)
109 – Lyme disease (2015) (0)
Treatment of chronic Lyme disease. (1996) (0)
OP0199 Immune Responses To Prevotella copri in Patients with Rheumatoid Arthritis (2016) (0)
Development of a multi-antigen panel for improved detection of Borrelia burgdorferi (2015) (0)
[The clinical and serological manifestations of Lyme disease in Russia]. (1995) (0)
IXth International Congress of Infectious and Parasitic Diseases Munich, July 20–26, 1986 (2005) (0)
Reply (2017) (0)
Heightened Pro-inflammatory Glycosylation of Borrelia burgdorferi IgG Antibodies in Synovial Fluid in Patients with Antibiotic-Refractory Lyme Arthritis. (2023) (0)
IDENTIFICATION D'UN ÉPITOPE DE LYMPHOCYTE T DE PREVOTELLA COPRI QUI INDUIT DES RÉPONSES DE LYMPHOCYTE T CHEZ DES PATIENTS ATTEINTS DE POLYARTHRITE RHUMATOÏDE (2017) (0)
Erythema migrans and early lyme disease. Discussion (1995) (0)
HumoralImmuneResponse toOuterSurface Protein C of Borrelia burgdorferi inLymeDisease: Roleofthe Immunoglobulin M Response intheSerodiagnosis ofEarly Infection (1994) (0)
Lyme Arthritis. (2022) (0)
Reply to Seligman et Al. (2014) (0)
Environmental risk and prevention of lyme disease. Discussion (1995) (0)
Infection and Autoimmunity in Antibiotic-Refractory Lyme Arthritis (2015) (0)
Conference Summary (1984) (0)
Acute monocytic arthritis. Discussion. (1979) (0)
5. Diagnosis and Treatment of Lyme Arthritis (2015) (0)
Lyme disease ( needle biopsy ) Reiter ' s disease Rheumatoid arthritis Chronic synovitis of unknown type Trauma Hemarthrosis due to hemophilia Acute suppurative arthritis Psoriatic arthritis Pseudogout (0)
Chronic LymeArthritis withHLA-DR4andAntibody Reactivity toOspAandOspB ofBorrelia burgdorferi (1993) (0)
Lyme disease; challenges and innovations (2011) (0)
Responsiveness of t-cell lines derived from leprosy patients with arthritis to the 65 kd mycobacterial protein (1996) (0)
In press, Infection and Immunity A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi 5 Running title: Immunogens of Borrelia burgdorferi in natural infections (2008) (0)
Routine endoscopy of the upper gastrointestinal tract in the evaluation of obstructive jaundice. (1985) (0)
A prospective study of tick bites in an endemic area for Lyme disease. (1989) (0)
Expression ofpublic idiotypes inpatients with Lymearthritis (2013) (0)
miR-155 and let-7a potentiate auto-inflammatory and tumor-like proliferative dysregulation in post-infectious Lyme arthritis synovial tissue (2017) (0)
LONG-TERM COURSE OF LYEM ARTHRITIS (1991) (0)
Relationship Between OspA and Lyme Arthritis (2009) (0)
Cytokine profiles in the erythema migrans skin lesions of Lyme disease (1994) (0)
Cell‐Mediated Cytotoxicity in Lyme Arthritis (2022) (0)
2nd European Symposium on Lyme Borreliosis. A NATO advanced research workshop. United Kingdom, 19-20 May 1993. Abstracts. (1993) (0)
Lyme disease. (1993) (0)
Whole genome sequencing of Borrelia burgdorferi isolates reveals linked clusters of plasmid-borne accessory genome elements associated with virulence (2023) (0)
First International Symposium on Lyme Dis. Yale University, November 16-18, 1983. (1984) (0)
Protein A-Reactive T Cells Is a Partial Agonist for Outer SurfaceL α LFA-1 Demonstrated at the Single Cell Level : Molecular Mimicry in Lyme Arthritis (2001) (0)
Crosseractivity study of lyme disease and lues (1993) (0)
Erythema Chronicum Migrans and Lyme Arthritis (2020) (0)
Effectiveness of early lyme disease treatment (1993) (0)
SP0177 Lyme disease – old and new insights (2013) (0)
with Rheumatoid Arthritis or Antibiotic-Refractory Lyme Arthritis (2009) (0)

This paper list is powered by the following services:

Other Resources About Allen Steere

en.wikipedia.org

What Schools Are Affiliated With Allen Steere?

Allen Steere is affiliated with the following schools:

Allen Steere's Academic­Influence.com Rankings